Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.42 |
| ▸ | NOS2 | P35228 | 3/20 | 0.41 |
| ▸ | NOS1 | P29475 | 2/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | KIF11 | P52732 | 5/20 | 0.38 |
| ▸ | ARG1 | P05089 | 1/20 | 0.38 |
| ▸ | ARG2 | P78540 | 1/20 | 0.38 |
| ▸ | BHMT | Q93088 | 2/20 | 0.37 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.37 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28326099 | 1.00 | SLC7A5 (0.42) | SLC7A5NOS2NOS1NOS3SLC1A3 | |
| SCHEMBL24068585 | 0.85 | SLC7A5 (0.42) | SLC7A5NOS2NOS1NOS3SLC1A3 | |
| SCHEMBL15539708 | 0.82 | SLC7A5 (0.46) | SLC7A5NOS2NOS1NOS3SLC1A3 | |
| SCHEMBL11680891 | 0.82 | SLC7A5 (0.46) | SLC7A5NOS2NOS1NOS3SLC1A3 | |
| SCHEMBL476398 | 0.80 | SLC7A5 (0.45) | SLC7A5NOS2NOS1NOS3SLC1A3 | |
| SCHEMBL2032831 | 0.80 | SLC7A5 (0.45) | SLC7A5NOS2NOS1NOS3SLC1A3 | |
| SCHEMBL360210 | 0.80 | SLC7A5 (0.45) | SLC7A5NOS2NOS1NOS3SLC1A3 | |
| SCHEMBL360209 | 0.80 | SLC7A5 (0.45) | SLC7A5NOS2NOS1NOS3SLC1A3 | |
| Cystine SCHEMBL28360714 | 0.80 | SLC7A5 (0.62) | SLC7A5NOS2NOS1NOS3SLC1A3 | |
| SCHEMBL11313182 | 0.80 | ARG1 (0.40) | SLC7A5NOS2NOS1NOS3SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114269722-B | Ergothioneine, S-methyl-ergothioneine and uses thereof | 贝尔维奇生物医学研究所(伊迪贝尔) | 2024-11-22 | — | — | CN | claimed |
| CN-114907546-B | Multifunctional polyurea acid ester derivative and preparation method and application thereof | 四川大学 | 2023-06-02 | — | — | CN | claimed |
| CN-114269722-A | Ergothioneine, S-methyl-ergothioneine and uses thereof | 贝尔维奇生物医学研究所(伊迪贝尔) | 2022-04-01 | — | — | CN | claimed |
| CN-114269722-B | Ergothioneine, S-methyl-ergothioneine and uses thereof | 贝尔维奇生物医学研究所(伊迪贝尔) | 2024-11-22 | — | — | CN | disclosed |
| CN-118613588-A | SERPINA modulating compositions and methods | 旗舰先锋创新VI有限责任公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-118556123-A | HBB modulating compositions and methods | 旗舰先锋创新VI有限责任公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-118489007-A | Methods and compositions for modulating genome | 旗舰先锋创新VI有限责任公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-118318041-A | Trans-recruitment of gene editing system components | 旗舰先锋创新VI有限责任公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118318037-A | Methods and compositions for modulating genome | 旗舰先锋创新VI有限责任公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118109826-A | Environment-friendly steel rust removing liquid and application thereof | 江苏成泰高科有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-116490610-A | Methods and compositions for modulating genome | 旗舰先锋创新VI有限责任公司 | 2023-07-25 | — | — | CN | disclosed |
| US-20030180804-A1 | Solid phase synthesis of chemical libraries | CORVAS INTERNATIONAL, INC | 2003-09-25 | — | — | US | disclosed |
| CN-1424878-A | Snack with improved flavor | PROCTER & GAMBLE (US) | 2003-06-18 | — | — | CN | disclosed |
| WO-2003040153-A1 | PROCESS FOR PREPARING SILYLORGANOMERCAPTANS | GENERAL ELECTRIC COMPANY (US) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003037326-A1 | SOLID PHASE SYNTHESIS OF CHEMICAL LIBRARIES | CORVAS INTERNATIONAL, INC. (US) | 2003-05-08 | — | — | WO | disclosed |
| US-6433206-B1 | CLEAVAGE OF SULFUR-SULFUR BOND | CROMPTON CORPORATION | 2002-08-13 | — | — | US | disclosed |
| EP-0654041-B1 | PEPTIDYL 4-AMINO-2,2-DIFLUORO-3-OXO-1,6-HEXANEDIOIC ACID DERIVATIVES AS ANTIINFLAMMATORY AGENTS | PFIZER (US) | 1998-07-01 | — | — | EP | disclosed |
| US-5739279-A | Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents | PFIZER INC. (US) | 1998-04-14 | — | — | US | disclosed |
| EP-0654041-A1 | PEPTIDYL 4-AMINO-2,2-DIFLUORO-3-OXO-1,6-HEXANEDIOIC ACID DERIVATIVES AS ANTIINFLAMMATORY AGENTS | PFIZER INC. (US) | 1995-05-24 | — | — | EP | disclosed |
| WO-1994003480-A1 | PEPTIDYL 4-AMINO-2,2-DIFLUORO-3-OXO-1,6-HEXANEDIOIC ACID DERIVATIVES AS ANTIINFLAMMATORY AGENTS | PFIZER INC. (US) | 1994-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030180804-A1 | Solid phase synthesis of chemical libraries | PEPD, DNPEP, PRSS1 | SLC7A5 905/4885NOS2 1951/4885NOS1 2126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.